Making a Comeback: Syphilitic Hepatitis in a Patient with Late Latent Syphilis—Case Report and Review of the Literature by Alina Plesa, Liliana Gheorghe, Corina Elena Hincu, Andreea Clim, Roxana Nemteanu

“…Virologic study revealed negative results for antibodies against common viral hepatitis and metabolic and autoimmune disease. …”
Get full text

Development of an Ex Vivo Assay for Identification of Infectious Hepatitis E Virus in Different Kinds of Food Samples by Renate W. Hakze-van der Honing, Sophie van Oort, René A. M. Dirks, Wim H. M. van der Poel

“…Hepatitis E virus (HEV) is a positive-sense single-stranded RNA virus and a major cause of acute viral hepatitis. HEV is responsible for 20 million infections worldwide in humans every year. …”
Get full text

Hepatocellular Carcinoma: Old and Emerging Therapeutic Targets by Greta Pessino, Claudia Scotti, Maristella Maggi, Immuno-HUB Consortium

“…HCC risk factors include non-viral hepatitis, alcohol abuse, environmental exposures, and genetic factors. …”
Get full text

The immunogenicity of GSK’s recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience by Caroline van den Ende, Cinzia Marano, Ayla van Ahee, Eveline M. Bunge, Laurence De Moerlooze

“…Introduction: The World Health Organization recommends hepatitis B virus (HBV) vaccines to be included in national immunization schedules everywhere, and has adopted the strategic goal of halting viral hepatitis as a major public health threat by 2030, under which vaccination plays a major role. …”
Get full text

Risks of Biologic Therapy and the Importance of Multidisciplinary Approach for an Accurate Management of Patients with Moderate-Severe Psoriasis and Concomitant Diseases by Ana Ion, Alexandra Maria Dorobanțu, Liliana Gabriela Popa, Mara Mădălina Mihai, Olguța Anca Orzan

“…Our aim was to perform an in-depth literature review and discuss the potential risks associated with biologic therapy in patients with psoriasis and concurrent diseases with a focus on the influence of novel therapeutic agents on liver function in the context of hepatopathies, particularly viral hepatitis. A multidisciplinary teamwork and periodic evaluation of psoriasis patients under biologic therapy is highly encouraged to obtain an accurate management for each case.…”
Get full text

Infections in the era of immunobiologicals by Ricardo Romiti, André Luís da Silva Hirayama, Adriana Maria Porro, Heitor de Sá Gonçalves, Luciane Donida Bartoli Miot, Sandra Maria Barbosa Durães, Silvio Alencar Marques

“…This article will discuss the main risks of infection associated with the use of immunobiologicals, addressing the risk in immunocompetent and immunosuppressed patients, vaccination, fungal infections, tuberculosis, leprosy, and viral hepatitis, and how to manage the patient in the most diverse scenarios.…”
Get full text

Streamlined and on-demand preparation of mRNA products on a universal integrated platform by Hongjuan Wei, Zhen Rong, Liyan Liu, Ye Sang, Jing Yang, Shengqi Wang

“…The proposed integrated platform shows advantages for the universal and on-demand preparation of mRNA products, offering the potential to facilitate broad access to mRNA technology and enable the development of mRNA products, including the rapid supply of new mRNA-based vaccines in pandemic situations and personalized mRNA-based therapies for oncology and chronic infectious diseases, such as viral hepatitis and acquired immune deficiency syndrome.…”
Get full text

SHARED: An International Collaboration to Unravel Hepatitis C Resistance by Anita Y.M. Howe, Francesca Ceccherini-Silberstein, Julia Dietz, Stephanie Popping, Jason Grebely, Chaturaka Rodrigo, Johan Lennerstrand, Mark W. Douglas, Milosz Parczewsk, P. Richard Harrigan, Jean-Michel Pawlotsky, Federico Garcia, SHARED Collaborators

Get full text

Syphilis in pregnant women in the municipality of Catanduvas-SC by R. S. Weber, G. C. M. Berber, P. Z. Tomasi, V. Beltrame

“…It was also observed that 91.8% of the pregnant women performed laboratory tests and three rapid tests for the diagnosis of Syphilis, Viral Hepatitis, and HIV, being a test in each gestational trimester. …”
Get full text

Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma by Patrizia Burra, Alberto Zanetto, Giacomo Germani

“…In Europe, alcohol abuse accounts for approximately half of all liver cancer cases and it will become the leading cause of hepatocellular carcinoma in the next future with the sharp decline of chronic viral hepatitis. The pathophysiology of alcohol-induced carcinogenesis involves acetaldehyde catabolism, oxidative stress and chronic liver inflammation. …”
Get full text

Hepatitis B Virus DNA Integration, Chronic Infections and Hepatocellular Carcinoma by Maria Bousali, George Papatheodoridis, Dimitrios Paraskevis, Timokratis Karamitros

“…The present review summarizes the advances in the research of HBV DNA integration, focusing on the evolutionary and molecular side of the integration events along with the arising clinical aspects in the light of WHO’s commitment to eliminate HBV and viral hepatitis by 2030.…”
Get full text

The Role of Infection and Autoimmunity in Urticaria and Angioedema as a Common Entity by Michael Rudenko

“…The author looked at evidence, using a keyword search, for the role of viral and bacterial infections in acute, acute recurrent, and chronic urticaria and angioedema, including COVID-19, herpes, viral hepatitis, and Helicobacter pylori.…”
Get full text

Perioperative management of patients with drug addiction by Yu.I. Markov

“…Common comorbidities in this population include human immunodeficiency virus, viral hepatitis, and infections caused by resistant strains of microorganisms. …”
Get full text

TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study by Frano Susak, Nina Vrsaljko, Adriana Vince, Neven Papic

Get full text

The risks of perinatal HIV/HCV co-infection and the evolution of treatment tactics of the disease in children (clinical case) by A. A. Khamatova, T. A. Chebotareva, J. F. Vlatskaya

“…The effectiveness of modern tactics for the treatment of HIV infection and chronic viral hepatitis C has been demonstrated.…”
Get full text

A Role for the Biological Clock in Liver Cancer by Gianluigi Mazzoccoli, Luca Miele, Giuseppe Marrone, Tommaso Mazza, Manlio Vinciguerra, Antonio Grieco

“…HCC onset and progression is related to B and C viral hepatitis, alcoholic and especially non-alcoholic fatty liver disease (NAFLD)-related milieu of fibrosis, cirrhosis, and chronic inflammation. …”
Get full text

Fructose and the Liver by Pablo Muriel, Pedro López-Sánchez, Erika Ramos-Tovar

“…Non-alcoholic fatty liver disease (NAFLD) is a term widely used to describe excessive fatty infiltration in the liver in the absence of alcohol, autoimmune disorders, or viral hepatitis; it is attributed to obesity, high sugar and fat consumption, and sedentarism. …”
Get full text

Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure by Mireia Casulleras, Ingrid W. Zhang, Cristina López-Vicario, Joan Clària

“…ACLF frequently occurs in close temporal relationship to a precipitating event, such as acute alcoholic, drug-induced or viral hepatitis or bacterial infection and, in cases without precipitating events, probably related to intestinal translocation of bacterial products. …”
Get full text

Chronic Hepatitis B Treatment: Current Perspectives on Telbivudine by Gian Paolo Caviglia, Chiara Rosso, Antonella Olivero, Maria Lorena Abate, Rinaldo Pellicano, Antonina Smedile

“…Hepatitis B virus (HBV) is the primary cause of chronic viral hepatitis worldwide. Currently, there are 5 oral nucleos(t)ide analogs (NAs) approved for chronic hepatitis B (CHB) treatment and include lamivudine, adefovir, telbivudine (LtD), entecavir (ETV), and tenofovir disoproxil fumarate (TDF). …”
Get full text

Hepatitis C Screening in Intravenous Drug Users Under Treatment with Methadone: An Action Reserch Study by Sina Mobasheri zadeh, Nazila Kassaian, Behrooz Ataei, zari Nokhodian, Peyman Adibi

“…Background: Intravenous drug users (IVDUs) are the most at risk group for viral hepatitis C and injection drug is responsible to more than 60% of HCV infected new cases worldwide. …”
Get full text